KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xylem (XYL) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Xylem (XYL) over the last 16 years, with Q3 2025 value amounting to $281.0 million.

  • Xylem's Free Cash Flow rose 1856.54% to $281.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $925.0 million, marking a year-over-year increase of 1171.5%. This contributed to the annual value of $942.0 million for FY2024, which is 6643.11% up from last year.
  • Per Xylem's latest filing, its Free Cash Flow stood at $281.0 million for Q3 2025, which was up 1856.54% from $207.0 million recorded in Q2 2025.
  • Xylem's Free Cash Flow's 5-year high stood at $475.0 million during Q4 2024, with a 5-year trough of -$130.0 million in Q1 2022.
  • For the 5-year period, Xylem's Free Cash Flow averaged around $140.9 million, with its median value being $149.0 million (2022).
  • In the last 5 years, Xylem's Free Cash Flow surged by 96000.0% in 2024 and then crashed by 35333.33% in 2025.
  • Xylem's Free Cash Flow (Quarter) stood at $139.0 million in 2021, then soared by 117.27% to $302.0 million in 2022, then rose by 19.54% to $361.0 million in 2023, then skyrocketed by 31.58% to $475.0 million in 2024, then crashed by 40.84% to $281.0 million in 2025.
  • Its Free Cash Flow stands at $281.0 million for Q3 2025, versus $207.0 million for Q2 2025 and -$38.0 million for Q1 2025.